Applied DNA Sciences Expands digitalDNA®

Software and Services Platform

A customer hub for marking, validation and authentication processes

STONY BROOK, NY, February 26, 2015. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter:

@APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today the expansion of its digitalDNA® software and services platform to enable customers' business process controls and supply chain partner collaboration throughout the entire lifecycle of marking, validating and authenticating goods. The new features enhance the foundation of bar code item tracking layered with SigNature® DNA as the forensic backstop.
New features on the secure cloud application include DNA custody management, forensic sample submission, CODA (certificate of DNA authentication) issuance, customer account administration, order placement, status tracking and reporting, and online training. Scanning bar code item numbers on
marked goods enables individuals to post or access information about a product such as its geo-location, original image or associated documentation. Consumers may take advantage of marketing information supplied by brand owners.
The system is operational and has managed the marking and authentications processes for over 40,000 electronics parts. Market-specific configurations have been demonstrated to businesses in textiles supply chain, printing/publishing, art and collectibles and law enforcement.
The cloud-based platform is designed to be customizable for the particular attributes of each customer's business and operates either as a stand-alone system or interfaced to an enterprise business system or other third-party platform. It conforms to strict security standards for ISO, PCI, and Federal Information Processing Standards.
This digitalDNA platform is designed as the data management and reporting hub for APDN's recently announced devices for DNA on-site authentication and optical mark in-field validation. In addition, using standard software and development tools, the system supports APDN-certified third-party devices such as InData Systems' covert "invisible bar code" scanning, and any browser-based enterprise or consumer devices such as mobile computers, smartphones and tablets.
Judy Murrah, APDN's CIO, comments that, "The expansion of our digitalDNA platform enhances the value of APDN's customer engagement by offering chain of custody visibility, supply chain quality and process control reporting, consumer confidence for brand owners and a seamless connection for our in- lab, in-field and on-site authentication and validation systems. A new business model of consulting services, software and device sales and other customer services is emerging for APDN."
"Our IT roadmap is now paralleling the content-service capacity of DNA. This platform sets the stage for APDN's next steps in the revolutionary integration of rich biotechnology-generated information and the information technology delivery systems within which they reside," said Dr. James Hayward, APDN's President and CEO."

About Applied DNA Sciences

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic
chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward-Looking Statement

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, and our subsequent quarterly report on Form 10-Q which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

investor contact: Debbie Bailey, 631-240-8817, debbie.bailey@adnas.com

media contact: Enrique Briz, Dian Griesel Int'l., 212-825-3210, ebriz@dgicomm.com

program contact: Judy Murrah, 631-240-8819, judy.murrah@adnas.com

web: www.adnas.com

twitter: @APDN

distributed by